These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Aspects of the genetical theory of the inborn "errors of metabolism". Harris H Triangle; 1971; 10(2):41-6. PubMed ID: 5110462 [No Abstract] [Full Text] [Related]
47. [Expected and unexpected side effects of drug therapy]. Ariëns EJ Pharm Weekbl; 1969 Feb; 104(8):153-69. PubMed ID: 4886956 [No Abstract] [Full Text] [Related]
48. The genetical background of therapy. Edwards JH Proc R Soc Med; 1970 Feb; 63(2):169-72. PubMed ID: 5440754 [No Abstract] [Full Text] [Related]
49. [Pharmacogenetics]. Mastrostefano MP; Di Pretoro L Acta Anaesthesiol; 1968; 19():Suppl 9:122+. PubMed ID: 5757550 [No Abstract] [Full Text] [Related]
51. [Receptors; from idea to reality]. Ariëns EJ Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1235-8. PubMed ID: 6310420 [No Abstract] [Full Text] [Related]
52. [Clinical significance of the induction and repression of the enzymes of drug metabolism]. Bushma MI; Lukienko PI Klin Med (Mosk); 1982 May; 60(5):16-21. PubMed ID: 7109509 [No Abstract] [Full Text] [Related]
53. Clinical pharmacology of drug metabolism and drug interactions: clinical, interethnical and regulatory aspects. Llerena A Drug Metabol Drug Interact; 2013; 28(1):1-3. PubMed ID: 23449520 [No Abstract] [Full Text] [Related]
58. Genetic disease. Can Med Assoc J; 1968 Feb; 98(8):414-6. PubMed ID: 4866089 [No Abstract] [Full Text] [Related]
59. [Congenital jaundice and lysosome diseases. Study of the ultrastructural cytochemical aspects]. Jean G; Travaglini P; Lambertenghi G Pathologica; 1967; 59(875):219-26. PubMed ID: 5614734 [No Abstract] [Full Text] [Related]
60. [Enzymes and enzymopathies in odontology]. Goudaert M; Danhiez P; Dufosse P Rev Stomatoodontol Nord Fr; 1971; 26(103):191-4. PubMed ID: 5154417 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]